January/February Issue

Editor’s Page
By Richard M. Bergenstal, MD, Chief Medical Editor


Enrollment Still Open for Largest Worldwide
Study of Type 1 Diabetes
By Laura Suarez, Managing Editor

Fenofibrate Can Reduce MI, Interventions
in Type 2 Patients
By Conni Bergmann Koury, Editor-in-Chief

Pioglitazone Reduced MI, Stroke and Death
in Diabetic Patients
By Conni Bergmann Koury, Editor-in-Chief

Diabetes in the UK: The Rising
Prevalence of Diabetes and Associated Mortality
By Sath Nag, MRCP; and Vincent Connolly, FRCP

High-normal Blood Glucose is Independent
Risk for Type 2 Diabetes
Reviewed by Amir Tirosh, MD, PhD


An Integrated Health Care Approach is Needed:
The Global Burden of Diabetic Foot Disease
Reviewed by Professor Andrew JM Boulton, MD, FRCP

NPWT vs Standard Care: Which is the Better
Treatment for Complex Wounds?
By Laura Suarez, Managing Editor
Reviewed by David G. Armstrong, DPM, PhD; and
Lawrence A. Lavery, DPM, MPH

Lower Extremity Disease More Prevalent
in Diabetic Population
By Laura Suarez, Managing Editor

Type 2 Diabetes Linked to Poor Cognitive
Function in Middle Age
Reviewed by Meena Kumari, PhD


PKC, Oxidative Stress and Retinal
Endothelial Cell Dysfunction
By Genevieve Renier, MD, PhD;
Jean-Claude Mamputu, PhD; and Ling Li, MD, PhD


Early Nephropathy Common in Mexican Type 2 Patients
Reviewed by Alfonso M. Cueto-Manzano, MD

Continuing Medical Education

Conference Coverage

Industry News and Innovations

Conference Calendar

5 Questions with Melinda Maryniuk